NHI on NYSE
NATIONAL HEALTH INVESTORS INC
American real estate investment trust based in Baltimore, active since 1991.
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with ACRES Commercial Realty Corp., ONE LIBERTY PROPERTIES INC or NEXPOINT DIVERSIFIED REAL ESTATE TRUST, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Interest29¢$57.4M
- Profit71¢$142.2M
Out of $80.1M in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Capital spending63¢$294.0M
- Dividends paid37¢$169.7M
Out of $236.6M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.3
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Rental income | $271.6M | $257.0M | $249.2M |
| Resident fees and services | $80.1M | $54.4M | $48.8M |
| Interest and other income | $24.0M | $23.7M | $21.8M |
| Revenues | $375.6M | $335.2M | $319.8M |
| Depreciation and amortization | $80.9M | $71.4M | $70.0M |
| Interest expense | $57.4M | $59.9M | $58.2M |
| Senior housing operating expenses | $60.9M | $42.3M | $39.6M |
| Legal | $2.7M | $1.1M | $507.0K |
| Franchise, excise and other taxes | $1.1M | $38.0K | $449.0K |
| General and administrative expenses | $26.9M | $20.7M | $19.3M |
| Proxy contest and related | $1.6M | $0 | $0 |
| Taxes and insurance on leased properties | $11.0M | $11.2M | $11.5M |
| Loan and realty (gains) losses, net | -$3.4M | $5.3M | $1.4M |
| Total operating expenses | $239.0M | $211.9M | $200.9M |
| Gains on operations transfers, net | $0 | $0 | $20.0K |
| Gains on sales of real estate properties, net | $456.0K | $6.7M | $14.7M |
| Gains from equity method investment | $3.7M | $402.0K | $555.0K |
| Loss on early retirement of debt | $0 | $0 | -$73.0K |
| Gains on forward equity sales agreements, net | $0 | $6.3M | $0 |
| Other income | $0 | $0 | $202.0K |
| Net income (loss) | $140.8M | $136.6M | $134.4M |
| Add: Net loss attributable to noncontrolling interests | $1.4M | $1.3M | $1.3M |
| Net income attributable to stockholders | $142.2M | $138.0M | $135.7M |
| Less: Net income attributable to unvested restricted stock awards | -$201.0K | -$118.0K | -$57.0K |
| Net income attributable to common stockholders | $142.0M | $137.9M | $135.6M |
| Basic (in shares) | 46.9M shares | 43.8M shares | 43.4M shares |
| Diluted (in shares) | 47.1M shares | 44.1M shares | 43.4M shares |
| Basic (in usd per share) | $3.03 | $3.14 | $3.13 |
| Diluted (in usd per share) | $3.02 | $3.13 | $3.13 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land | $221.7M | $191.9M | ||
| Buildings, building improvements and intangible assets | $3.1B | $2.8B | ||
| Construction in progress | $18.2M | $10.6M | ||
| Total real estate properties | $3.3B | $3.0B | ||
| Less: Accumulated depreciation and amortization | -$822.0M | -$742.3M | ||
| Total real estate properties, net | $2.5B | $2.2B | ||
| Mortgage and other notes receivable, net of credit loss reserves | $203.3M | $268.9M | ||
| Cash and cash equivalents | $19.6M | $24.3M | $22.3M | |
| Straight-line rents receivable | $78.9M | $87.2M | ||
| Assets held for sale, net | $3.6M | $0 | ||
| Total Assets | $2.8B | $2.6B | ||
| Debt, net | $1.2B | $1.1B | ||
| Dividends payable | $44.4M | $41.1M | ||
| Deferred income | $5.0M | $4.3M | ||
| Total Liabilities | $1.3B | $1.2B | ||
| Redeemable noncontrolling interest | $10.2M | $9.8M | $9.7M | |
| Common stock | $483.0K | $457.0K | ||
| Capital in excess of par value | $1.9B | $1.7B | ||
| Retained earnings | $2.7B | $2.6B | ||
| Cumulative dividends | -$3.1B | -$3.0B | ||
| Total National Health Investors, Inc. stockholders equity | $1.5B | $1.4B | ||
| Noncontrolling interests | $8.2M | $8.9M | ||
| Total equity | $1.5B | $1.4B | $1.3B | $1.3B |
| Total liabilities and equity | $2.8B | $2.6B | ||
| Mortgage and other notes receivable, net of reserve | $15.4M | $20.2M | ||
| Common stock, par value (in usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 100.0B shares | 100.0B shares | ||
| Common stock, shares issued (in shares) | 48.3M shares | 45.7M shares | ||
| Common stock, shares outstanding (in shares) | 48.3M shares | 45.7M shares | ||
| Other assets, net | $17.8M | $22.8M | ||
| Accounts payable and accrued liabilities | -$43.7M | -$37.8M |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land | $221.7M | $191.9M | ||
| Buildings, building improvements and intangible assets | $3.1B | $2.8B | ||
| Construction in progress | $18.2M | $10.6M | ||
| Total real estate properties | $3.3B | $3.0B | ||
| Less: Accumulated depreciation and amortization | -$822.0M | -$742.3M | ||
| Total real estate properties, net | $2.5B | $2.2B | ||
| Mortgage and other notes receivable, net of credit loss reserves | $203.3M | $268.9M | ||
| Cash and cash equivalents | $19.6M | $24.3M | $22.3M | |
| Straight-line rents receivable | $78.9M | $87.2M | ||
| Assets held for sale, net | $3.6M | $0 | ||
| Total Assets | $2.8B | $2.6B | ||
| Debt, net | $1.2B | $1.1B | ||
| Dividends payable | $44.4M | $41.1M | ||
| Deferred income | $5.0M | $4.3M | ||
| Total Liabilities | $1.3B | $1.2B | ||
| Redeemable noncontrolling interest | $10.2M | $9.8M | $9.7M | |
| Common stock | $483.0K | $457.0K | ||
| Capital in excess of par value | $1.9B | $1.7B | ||
| Retained earnings | $2.7B | $2.6B | ||
| Cumulative dividends | -$3.1B | -$3.0B | ||
| Total National Health Investors, Inc. stockholders equity | $1.5B | $1.4B | ||
| Noncontrolling interests | $8.2M | $8.9M | ||
| Total equity | $1.5B | $1.4B | $1.3B | $1.3B |
| Total liabilities and equity | $2.8B | $2.6B | ||
| Mortgage and other notes receivable, net of reserve | $15.4M | $20.2M | ||
| Common stock, par value (in usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 100.0B shares | 100.0B shares | ||
| Common stock, shares issued (in shares) | 48.3M shares | 45.7M shares | ||
| Common stock, shares outstanding (in shares) | 48.3M shares | 45.7M shares | ||
| Other assets, net | $17.8M | $22.8M | ||
| Accounts payable and accrued liabilities | -$43.7M | -$37.8M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $140.8M | $136.6M | $134.4M |
| Depreciation and amortization | $80.9M | $71.4M | $70.0M |
| Amortization of lease incentives | $2.9M | $2.9M | $2.5M |
| Amortization of commitment fees and notes receivable discounts | -$920.0K | -$116.0K | -$412.0K |
| Amortization of debt issuance costs and discounts | $3.4M | $3.8M | $2.6M |
| Payments of lease incentives | $0 | $0 | -$10.0M |
| Share-based compensation expense | $5.6M | $4.2M | $4.6M |
| Non-cash rental income related to operations transfers upon early lease terminations | -$1.4M | $0 | $0 |
| Other non-cash rental income | $0 | $0 | -$2.5M |
| Non-cash changes in straight-line rents receivable | $7.3M | -$3.0M | -$7.0M |
| Non-cash interest income on mortgage and other notes receivable | -$1.7M | -$124.0K | -$1.3M |
| Non-cash lease incentives recognized as interest and other income | $0 | -$100.0K | $0 |
| Loan and realty (gains) losses, net | -$3.4M | $5.3M | $1.4M |
| Gains on sales of real estate properties, net | -$456.0K | -$6.7M | -$14.7M |
| Gains from equity method investment | -$3.7M | -$402.0K | -$555.0K |
| Loss on early retirement of debt | $0 | $0 | $73.0K |
| Gains on forward equity sales agreements, net | $0 | -$6.3M | $0 |
| Other assets, net | $57.0K | -$1.9M | -$705.0K |
| Accounts payable and other liabilities | $5.5M | $3.3M | $5.9M |
| Deferred income | $1.7M | -$1.1M | $101.0K |
| Net cash provided by operating activities | $236.6M | $207.8M | $184.4M |
| Acquisitions of real estate properties | -$274.1M | -$138.1M | -$38.1M |
| Investments in existing real estate properties and equipment | -$20.0M | -$19.8M | -$11.5M |
| Proceeds from sales of real estate properties | $0 | $6.2M | $57.0M |
| Investments in mortgage and other notes receivable | -$71.1M | -$60.4M | -$35.6M |
| Payments received on mortgage and other notes receivable | $92.3M | $19.4M | $13.5M |
| Distributions from equity method investment | $3.7M | $402.0K | $3.1M |
| Net cash used in investing activities | -$269.1M | -$192.3M | -$11.6M |
| Proceeds from revolving credit facility | $694.0M | $449.7M | $364.0M |
| Repayments of revolving credit facility | -$821.2M | -$363.5M | -$161.0M |
| Borrowings on bank term loan | $0 | $0 | $200.0M |
| Repayments of bank term loan and private placement notes | -$200.8M | -$75.4M | -$415.4M |
| Proceeds from issuance of senior notes | $346.2M | $0 | $0 |
| Payments of debt issuance costs | -$3.9M | -$3.5M | -$2.7M |
| Proceeds from issuance of common shares, net | $181.5M | $142.4M | $0 |
| Payments of equity issuance costs | -$767.0K | -$930.0K | $0 |
| Capital contributions from noncontrolling interests | $1.7M | $1.2M | $3.0M |
| Distributions paid to noncontrolling interests | -$917.0K | -$1.2M | -$1.3M |
| Dividends paid to stockholders | -$169.7M | -$156.5M | -$156.2M |
| Taxes paid related to net settlement of stock incentive awards | -$456.0K | -$5.8M | $0 |
| Net cash provided by (used in) financing activities | $25.7M | -$13.6M | -$169.7M |
| (Decrease) increase in cash, cash equivalents and restricted cash | -$6.9M | $1.9M | $3.1M |
| Interest paid, net of amounts capitalized | $51.5M | $55.4M | $51.9M |
| Real estate properties acquired to settle mortgage notes receivable | $50.8M | $22.2M | $14.2M |
| Increase in liabilities associated with acquisitions of real estate properties | $778.0K | $0 | $0 |
| Assets received upon early lease terminations | $1.4M | $0 | $0 |
| Right of use assets acquired in exchange for finance lease liabilities | $139.0K | $344.0K | $101.0K |
| Changes in other assets related to sales of real estate properties | $0 | $0 | $325.0K |
| Changes in accounts payable related to real estate property renovations | -$95.0K | -$250.0K | $0 |
| Noncash or Part Noncash Acquisition, Payables Assumed | $0 | $189.0K | $0 |
| Changes in accounts payable related to noncontrolling interest distributions | -$241.0K | $16.0K | $6.0K |
| Increases in notes receivable from sales of real estate properties | $0 | $9.0M | $2.2M |
| Reclassification of prepaid equity issuance costs to capital in excess of par value | $0 | $471.0K | $275.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led NATIONAL HEALTH INVESTORS INC, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerD. Eric Mendelsohn Aug 13, 2015 to now11
- Chief executive officerJames Justin Hutchens Aug 8, 2011 to Apr 2, 201512
- Chief executive officerW. Andrew Adams Sep 1, 2009 to Mar 4, 201113
- PresidentD. Eric Mendelsohn Aug 13, 2015 to now11
- PresidentJames Justin Hutchens Feb 26, 2009 to Apr 2, 201514
- PresidentW. Andrew Adams Feb 1, 2007 to Mar 6, 200915
- Chief financial officerTodd Michael Siefert Jul 2, 2026 to now16
- Chief financial officerJohn L. Spaid Feb 13, 2020 to Jul 2, 202617
- Chief operating officerChristian Ken Maingot Jul 30, 2026 to now18
- Chief operating officerJames Justin Hutchens Feb 26, 2009 to Feb 25, 201114
Board members and other officers (24)
- SVP, Legal AffairsElizabeth Jackson Blankenship Mar 4, 2026 to now19
- SVP/Chief Accounting OfficerDavid L. Travis May 1, 2020 to now20
- Chief Accounting OfficerRonald Reel V. Nov 15, 2019 to Feb 25, 202021
- Exec. VP of FinanceJohn L. Spaid Mar 8, 2016 to Feb 25, 201922
- EVP - Corporate FinanceD. Eric Mendelsohn Jan 26, 2015 to Jun 11, 201523
- EVP - InvestmentsKevin Carlton Pascoe Jan 26, 2015 to now24
- Chief Credit OfficerKristin Sallee Gaines Mar 3, 2010 to now25
- Senior V.P. & TreasurerCharlotte A. Swafford Jan 9, 2007 to Jan 9, 200726
- Senior V.P. & ControllerDonald K. Daniel Jan 9, 2007 to Jan 9, 200727
- Chief Accounting OfficerRoger R. Hopkins Jan 9, 2007 to Feb 25, 201928
- Senior Vice President, FinanceKenneth D. Denbesten Mar 13, 2006 to Apr 24, 200829
- SecretaryRichard F. Laroche Jr. May 4, 2006 to May 4, 200630
- Board memberLilly Donohue Feb 27, 2026 to now31
- Board memberCandice W. Todd Jan 3, 2025 to now32
- Board memberRobert Chapin Apr 22, 2025 to now33
- Board memberD. Eric Mendelsohn May 8, 2023 to now34
- Board memberTracy M. J. Colden Jun 1, 2022 to now35
- Board memberCharlotte A. Swafford May 8, 2020 to now36
- Board memberRobert G. Adams May 8, 2020 to now37
- Board memberJames R. Jobe May 8, 2013 to now38
- Board memberJames Justin Hutchens Aug 8, 2011 to Apr 2, 201512
- Board memberW. Andrew Adams Feb 1, 2007 to Oct 3, 202415
- Board memberRobert T. Webb Jan 31, 2006 to Sep 5, 202439
- Board memberRichard F. Laroche Jr. May 4, 2006 to Mar 12, 200830
Timeline
Filings
310 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 97 major events, 131 insider forms, 11 large holders, 49 other. The latest 20:
- Aug 27, 20268-K EDGAR
- Aug 17, 2026144 EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 202610-Q EDGAR
- Aug 7, 2026SCHEDULE 13G EDGAR
- Jul 30, 20264 PRIMARY DOCUMENT EDGAR
- Jul 30, 20263 PRIMARY DOCUMENT EDGAR
- Jul 27, 20268-K EDGAR
- Jul 8, 2026SCHEDULE 13G/A EDGAR
- Jul 2, 20263 PRIMARY DOCUMENT EDGAR
- Jul 1, 20268-K EDGAR
- Jul 1, 20268-K EDGAR
- Jun 15, 20264 PRIMARY DOCUMENT EDGAR
- Jun 9, 20264 PRIMARY DOCUMENT EDGAR
- Jun 5, 20264 PRIMARY DOCUMENT EDGAR
- Jun 1, 20268-K EDGAR
- May 29, 20268-K EDGAR
- May 7, 20264 PRIMARY DOCUMENT EDGAR
The 310 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 11 such filings since October 2021, the latest 10:
- Aug 7, 2026SCHEDULE 13G
- Jul 8, 2026SCHEDULE 13G/A
- Apr 30, 2026SCHEDULE 13G
- Apr 29, 2026SCHEDULE 13G
- Mar 27, 2026SCHEDULE 13G/A
- Feb 13, 2024SC 13G/A
- Jan 8, 2024SC 13G/A
- Feb 9, 2023SC 13G/A
- Jan 24, 2023SC 13G
- Feb 10, 2022SC 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 8,733,237 | $666.0M | 0.0% | +3,926,380 |
| Vanguard Portfolio Management LLC | 4,630,646 | $353.1M | 0.0% | +488,430 |
| State Street Corp | 2,735,937 | $211.1M | 0.0% | +761,547 |
| Vanguard Capital Management LLC | 2,099,145 | $160.1M | 0.0% | +14,525 |
| Principal Financial Group Inc | 1,977,094 | $150.8M | 0.1% | +276,186 |
| Bank of New York Mellon Corp | 1,606,463 | $122.5M | 0.0% | +1,091,732 |
| Geode Capital Management, LLC | 1,402,775 | $107.0M | 0.0% | +91,535 |
| Bank Of America Corp /de/ | 1,019,379 | $77.7M | 0.0% | +26,577 |
| Charles Schwab Investment Management Inc | 880,321 | $67.1M | 0.0% | +54,330 |
| Nomura Asset Management International Inc. | 870,365 | $66.4M | 0.1% | −26,937 |
| Dimensional Fund Advisors LP | 675,739 | $51.5M | 0.0% | −10,510 |
| Norges Bank | 672,355 | $51.3M | 0.0% | New |
| Northern Trust Corp | 608,688 | $46.4M | 0.0% | +45,841 |
| Morgan Stanley | 444,043 | $33.9M | 0.0% | +64,157 |
| Jpmorgan Chase & Co | 415,413 | $32.4M | 0.0% | −571,179 |
| UBS Group AG | 396,229 | $30.2M | 0.0% | +268,595 |
| Two Sigma Investments, LP | 335,445 | $25.6M | 0.0% | −84,629 |
| Vanguard Fiduciary Trust Co | 321,018 | $24.5M | 0.0% | +9,275 |
| Legal & General Group Plc | 285,144 | $21.7M | 0.0% | +53,401 |
| Bowen Hanes & Co Inc | 260,000 | $21.0M | 0.5% | No change |
| Sound Income Strategies, LLC | 270,252 | $20.6M | 0.9% | +12,540 |
| Prudential Financial Inc | 257,108 | $19.6M | 0.0% | −880,075 |
| Algert Global LLC | 248,865 | $19.0M | 0.2% | +103,285 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 242,935 | $18.5M | 0.0% | +6,627 |
| Goldman Sachs Group Inc | 235,078 | $17.9M | 0.0% | +18,350 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
12 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jul 10, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −15.1% | Report |
| Jan 15, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −29.8% | Report |
| Sep 1, 2022 | Virginia FoxxRepublican, House | Sale | $50,001 - $100,000 | +92.8% | Report |
| Jun 28, 2022 | Virginia FoxxRepublican, House | Buy | $15,001 - $50,000 | −96.3% | Report |
| Jan 28, 2022 | Virginia FoxxRepublican, House | Sale | $50,001 - $100,000 | +60.7% | Report |
| Nov 8, 2021 | Virginia FoxxRepublican, House | Buy | $1,001 - $15,000 | −43.9% | Report |
| Aug 9, 2021 | Virginia FoxxRepublican, House | Buy | $1,001 - $15,000 | −74.2% | Report |
| Aug 6, 2021 | Virginia FoxxRepublican, House | Buy | $1,001 - $15,000 | −75.9% | Report |
| May 27, 2021 | Virginia FoxxRepublican, House | Buy | $15,001 - $50,000 | −83.9% | Report |
| May 12, 2021 | Virginia FoxxRepublican, House | Buy | $15,001 - $50,000 | −90.3% | Report |
| Apr 19, 2021 | Virginia FoxxRepublican, House | Buy | $50,001 - $100,000 | −96.3% | Report |
| Mar 31, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −166.8% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARJames Justin Hutchens, President
- 15SEC EDGARW. Andrew Adams, President
- 16
- 17
- 18
- 19
- 20
- 21
- 22SEC EDGARJohn L. Spaid, Exec. VP of Finance
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30SEC EDGARRichard F. Laroche Jr., Secretary
- 31SEC EDGARLilly Donohue, Board member
- 32SEC EDGARCandice W. Todd, Board member
- 33SEC EDGARRobert Chapin, Board member
- 34SEC EDGARD. Eric Mendelsohn, Board member
- 35SEC EDGARTracy M. J. Colden, Board member
- 36SEC EDGARCharlotte A. Swafford, Board member
- 37SEC EDGARRobert G. Adams, Board member
- 38SEC EDGARJames R. Jobe, Board member
- 39SEC EDGARRobert T. Webb, Board member
- 40